Markets
S&P 500$7,673.52-0.58%|Dow Jones$52,786.07-1.18%|Nasdaq Composite$26,421.41-0.32%|FTSE 100£10,811.7-0.10%|DAX€26,007.63+0.00%|CAC 40€8,317.98+0.21%|Nikkei 225¥65,152.76-0.33%|Shanghai Composite$3,949.5+0.18%|Hang Seng$25,254.86-0.25%|MSCI World$208.63-0.88%|Apple$316.22-1.18%|Microsoft$493.95-1.14%|NVIDIA$225.73-1.64%|Alphabet$338.36-0.13%|Amazon$256.97-0.50%|Meta$613.48-0.28%|Tesla$368.16+4.33%|SpaceX$153.47+3.78%|LVMH€426.55-0.87%|Hermès€1,442.5-2.10%|Berkshire$505.83-0.23%|JPMorgan$353.51-1.45%|Barclays$498.05-0.32%|GBP / USD1.3560+0.14%|GBP / EUR1.1643+0.01%|GBP / JPY207.7500-0.21%|GBP / CHF1.0959+-0.00%|GBP / CAD1.8673+0.06%|GBP / AUD1.8749-0.05%|GBP / NZD2.3144+0.10%|GBP / AED4.9792+0.14%|US Dollar Index (DXY)98.6380-0.14%|AUD / USD0.7235+0.20%|NZD / USD0.5861+0.05%|USD / EUR0.8589-0.12%|USD / JPY153.2080-0.35%|USD / CHF0.8081-0.14%|USD / CAD1.3771-0.09%|USD / CNY6.7062-0.06%|USD / INR95.0800+0.29%|USD / SGD1.2637-0.07%|USD / HKD7.8420+0.01%|USD / SEK9.5700-0.16%|USD / NOK9.2054-0.15%|USD / MXN16.9075+0.00%|USD / ZAR15.9868-0.01%|USD / TRY48.4715+0.06%|EUR / USD1.1643+0.12%|EUR / GBP0.8584-0.01%|EUR / JPY178.3580-0.21%|EUR / CHF0.9408-0.01%|EUR / CAD1.6030+0.04%|EUR / AUD1.6094-0.06%|Bitcoin$79,162+0.91%|Ethereum$2,499+0.58%|Tether$1.00-0.01%|Binance Coin$755+0.40%|Solana$105+1.21%|XRP$1.44+1.34%|Cardano$0.22+0.52%|USD Coin$1.00-0.01%|TRON$0.34-0.12%|Dogecoin$0.09+0.53%|S&P 500$7,673.52-0.58%|Dow Jones$52,786.07-1.18%|Nasdaq Composite$26,421.41-0.32%|FTSE 100£10,811.7-0.10%|DAX€26,007.63+0.00%|CAC 40€8,317.98+0.21%|Nikkei 225¥65,152.76-0.33%|Shanghai Composite$3,949.5+0.18%|Hang Seng$25,254.86-0.25%|MSCI World$208.63-0.88%|Apple$316.22-1.18%|Microsoft$493.95-1.14%|NVIDIA$225.73-1.64%|Alphabet$338.36-0.13%|Amazon$256.97-0.50%|Meta$613.48-0.28%|Tesla$368.16+4.33%|SpaceX$153.47+3.78%|LVMH€426.55-0.87%|Hermès€1,442.5-2.10%|Berkshire$505.83-0.23%|JPMorgan$353.51-1.45%|Barclays$498.05-0.32%|GBP / USD1.3560+0.14%|GBP / EUR1.1643+0.01%|GBP / JPY207.7500-0.21%|GBP / CHF1.0959+-0.00%|GBP / CAD1.8673+0.06%|GBP / AUD1.8749-0.05%|GBP / NZD2.3144+0.10%|GBP / AED4.9792+0.14%|US Dollar Index (DXY)98.6380-0.14%|AUD / USD0.7235+0.20%|NZD / USD0.5861+0.05%|USD / EUR0.8589-0.12%|USD / JPY153.2080-0.35%|USD / CHF0.8081-0.14%|USD / CAD1.3771-0.09%|USD / CNY6.7062-0.06%|USD / INR95.0800+0.29%|USD / SGD1.2637-0.07%|USD / HKD7.8420+0.01%|USD / SEK9.5700-0.16%|USD / NOK9.2054-0.15%|USD / MXN16.9075+0.00%|USD / ZAR15.9868-0.01%|USD / TRY48.4715+0.06%|EUR / USD1.1643+0.12%|EUR / GBP0.8584-0.01%|EUR / JPY178.3580-0.21%|EUR / CHF0.9408-0.01%|EUR / CAD1.6030+0.04%|EUR / AUD1.6094-0.06%|Bitcoin$79,162+0.91%|Ethereum$2,499+0.58%|Tether$1.00-0.01%|Binance Coin$755+0.40%|Solana$105+1.21%|XRP$1.44+1.34%|Cardano$0.22+0.52%|USD Coin$1.00-0.01%|TRON$0.34-0.12%|Dogecoin$0.09+0.53%|
Business

XOXO Soda makes its Sainsbury’s debut with a meal deal twist

Discover XOXO Soda's exciting debut at Sainsbury's with a meal deal twist. Enjoy bold flavors and gut-friendly benefits with XOXO Soda today!

08 September 2025·3 min read
XOXO Soda makes its Sainsbury’s debut with a meal deal twist

There’s a new name sliding into the nation’s lunchtime rotation, and it comes wrapped in bright, bold cans with a promise your gut will thank you for. XOXO Soda, the prebiotic soft drink brand that has been quietly rewriting the rules of refreshment since 2023, has just landed a nationwide listing with Sainsbury’s. From this month, its Watermelon and Tropical flavours will be stacked front-and-centre in 450 stores across the UK, available as part of the supermarket’s coveted meal deal.

It’s not just another shelf placement. This move makes XOXO the first prebiotic-only soda brand to claim a spot in a major grocer’s meal deal line-up – a coup that signals just how fast the brand is cutting through. The partnership follows its earlier breakthrough with Co-op and shows there’s appetite not just for full-flavour soft drinks, but for drinks that offer something extra.

The appeal? XOXO has always been about taste first, health credentials second – but crucially, never at the expense of either. Each 330ml can is packed with six grams of plant-based prebiotic fibre, designed to keep your gut happy while serving the kind of bold, juicy flavours that wouldn’t look out of place on a cocktail list.

Take the Watermelon soda: sweet, unapologetically bold, and practically engineered for main character energy. Or the Tropical – a fizzy island escape that tastes like mango and citrus caught in a daydream. These aren’t the polite, watered-down alternatives that usually haunt the low-sugar aisle; they’re full-on flavour bombs that also happen to be low in sugar, low in calories, and built for the Instagram grid.

For Rory Paterson, XOXO’s co-founder and chief executive, the Sainsbury’s launch is a milestone. “We started XOXO to shake up a category that had gone flat. Soda should taste amazing, look great and make you feel good too,” he says. “Landing a major UK grocery listing with Sainsbury’s, and becoming the first prebiotic-only soda in the meal deal – is a huge moment for us, and for the category.”

Founded just two years ago, XOXO has already become the largest prebiotic soda brand in Europe. Its aesthetic – bold blocks of colour, playful copy, cans designed to be photographed – has helped it carve out a distinct cultural identity. But it’s the combination of taste and function that’s driving momentum. In a market where consumers are increasingly conscious of sugar, calories and gut health, XOXO has managed to make the sensible choice feel like the fun one.

From 8 September, shoppers can find XOXO Watermelon and Tropical in 450 Sainsbury’s stores nationwide, priced at £2 per 330ml can, or as part of the £3.95 meal deal. Expect to see them wedged between your wrap and your crisps, ready to turn a quick lunch into a mini mood boost.

Because sometimes, the best pick-me-up is the soda that loves you back.

Share

Continue Reading

More Business